Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Julius Oni

Orthopaedic Surgery Philadelphia, PA Medical Doctor

NPI 1083810428 CMS profile 275778

5501 Old York Rd, Willowcrest Bldg. 4Th Floor, Philadelphia, PA 19141

Open in the dashboard

General payments

$157,447

176 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Julius Oni of Philadelphia, PA is reported in the CMS Open Payments database as having received $157,447 across 176 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $25,970 16
2024 General $44,108 46
2023 General $33,392 50
2022 General $16,370 34
2021 General $13,313 11
2020 General $272 5
2019 General $24,021 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Julius Oni
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Julius Oni were reported at $25,970. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Julius Oni Orthopaedic Surgery median Middle half National median
2019 $24,021 $644 $140–$2,844 $163
2020 $272 $312 $75–$1,860 $114
2021 $13,313 $520 $117–$2,495 $132
2022 $16,370 $598 $128–$2,731 $149
2023 $33,392 $461 $128–$2,264 $160
2024 $44,108 $497 $134–$2,475 $164
2025 $25,970 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $150,843 157 payments
  2. Medical Device Business Services, Inc. $4,537 2 payments
  3. Exactech, Inc. $762 4 payments
  4. Stryker Corporation $564 1 payment
  5. Davol Inc. $133 1 payment
  6. Bone Support Inc. $125 1 payment
  7. Baxter Healthcare $107 2 payments
  8. Medacta USA, Inc. $107 1 payment
  9. Smith+Nephew, Inc. $88 2 payments
  10. Encore Medical, LP $77 2 payments
  11. Other $104 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $76,763 34 payments
  2. Education $59,465 17 payments
  3. Travel and Lodging $14,622 57 payments
  4. Food and Beverage $6,598 68 payments
Products named General payments · program years 2019–2025
  1. Persona $103,926 60 payments
  2. Continuum $23,500 5 payments
  3. M L Taper $19,500 4 payments
  4. ACTIS $4,388 1 payment
  5. NexGen Knees $4,125 3 payments
  6. mymobility Platform $3,750 5 payments
  7. Avenir $3,537 3 payments
  8. Arcos $3,500 2 payments
  9. LCCK NexGen $3,000 2 payments
  10. NexGen Knees $3,000 2 payments
  11. Other $7,355 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 17 billing codes

Paid by Medicare

$67,900

Of which drugs: $1,219

Medicare patients

183

Average age 73

Services billed

632

122 women, 61 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Depression 27%
Ischemic heart disease 26%
Chronic kidney disease 23%
Heart failure 17%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 32 368 $280

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

176 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record